NewsRx

Search our medical news database

Proteomics

Estrogen receptor acetylation enhances receptor DNA binding

Published in Women's Health Weekly, August 24th, 2006

According to a study from the United States, acetylation of estrogen receptor alpha by p300 at Lys 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.

"Using a variety of biochemical and cell-based approaches, we show that estrogen receptor alpha(ER alpha) is acetylated by the p300 acetylase in a ligand- and steroid receptor coactivator-dependent manner," wrote M.Y. Kim and colleagues, Cornell University.

"Using mutagenesis and mass spectrometry, we identified two conserved Lys residues in ER alpha (Lys266 and Lys268) that are the primary targets of p300-mediated acetylation. These residues are...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook